ITGR STOCK NEWS: A Class Action Was Filed on Behalf of Integer Holdings Corporation Shareholders for Securities Fraud, Contact BFA Law by February 9 Deadline

New York, New York–(Newsfile Corp. – January 7, 2026) – Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Integer Holdings Corporation (NYSE: ITGR) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations […]

BRBR STOCK NEWS: A Securities Fraud Investigation has been Initiated on behalf of BellRing Brands Shareholders, Contact BFA Law if You Suffered Losses

New York, New York–(Newsfile Corp. – January 7, 2026) – Leading international securities law firm Bleichmar Fonti & Auld LLP announces an investigation into BellRing Brands, Inc. (NYSE: BRBR) for potential violations of the federal securities laws. If you invested in BellRing, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/bellring-brands-inc-class-action-lawsuit. Why is BellRing

SmartRecruiters Names “The Orchestrator” as Job Title of the Year

SmartRecruiters Names “The Orchestrator” as Job Title of the Year New hiring data highlights a shift toward coordination and end-to-end ownership as organizations redesign how work gets done GlobeNewswire January 07, 2026 SAN FRANCISCO, Jan. 07, 2026 (GLOBE NEWSWIRE) — SmartRecruiters, the recruiting AI company and an SAP company, today announced “The Orchestrator” as its

Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment, Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf

(NASDAQ:CYTK),(NASDAQ:LFCR),(NYSE:MOH),(NASDAQ:WBTN), PHILADELPHIA, Jan. 07, 2026 (GLOBE NEWSWIRE) — Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company. If you purchased Cytokinetics, Inc. (NASDAQ: CYTK) shares prior to December

ARE STOCK NEWS: A Class Action was filed on behalf of Alexandria Real Estate Equities, Inc. Shareholders for Securities Fraud, Contact BFA Law by January 26 Deadline

New York, New York–(Newsfile Corp. – January 7, 2026) – Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. (NYSE: ARE) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the

Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment, Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf

Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment, Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf GlobeNewswire January 07, 2026 PHILADELPHIA, Jan. 07, 2026 (GLOBE NEWSWIRE) — Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on

The Glimpse Group Strategic Update Letter – Calendar Year 2026

NEW YORK, NY / ACCESS Newswire / January 7, 2026 / The Glimpse Group, Inc. ("Glimpse") (NASDAQ:VRAR), a diversified Immersive Technology platform company providing enterprise-focused Immersive Technology, Spatial Computing and Artificial Intelligence ("AI") driven software and services, provided a strategic update as we begin calendar year 2026 ("CY ‘26"). Business Commentary by President & CEO

Salarius Pharmaceuticals Changes Corporate Name to Decoy Therapeutics and Nasdaq Ticker Symbol to DCOY Reflecting Focus on Next-Generation Peptide Conjugate Therapeutics

(NASDAQ:SLRX), Trading under DCOY to commence on January 8, 2026 Company's proprietary peptide-conjugate platform leverages AI-enabled computational infrastructure to accelerate candidate selection Capital-efficient 2026 plan features advancing lead antiviral into the clinic while expanding pipeline and partnership opportunities CAMBRIDGE, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) (Salarius) announces it will

RenX Enterprises Completes Purchase of Komptech Crambo Shredder and Diamond Z Horizontal Grinder Following Strong Operating Performance

(NASDAQ:RENX),(NASDAQ:SGD), MIAMI, FL, Jan. 07, 2026 (GLOBE NEWSWIRE) — RenX Enterprises, Inc. (the “Company”) (NASDAQ: RENX), formerly known as Safe and Green Development Corporation, today announced that it has completed the purchase of a Komptech Crambo shredder and a Diamond Z horizontal grinder that had previously been deployed under a rental arrangement. The Company elected

Critical Minerals Take Center Stage as U.S. Accelerates Push for Domestic Supply Security

(Other OTC:MILIF),(NASDAQ:PPTA),(TSX:PPTA),(NYSE:UAMY),(NYSE:MP),(NasdaqGM:CRML),(CNSX:MILI),(Boerse Frankfurt – Freiverkehr:QN90), NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — The Western world is entering a strategic race to secure domestic supplies of critical minerals, creating a compelling opportunity set for investors focused on resource security and long-term value for active miners that include Military Metals Corp. (OTCQB: MILIF) (CSE: MILI), Perpetua

Scroll to Top